Express Scripts Holding
The 10-second takeaway
Comparing the upcoming quarter with the prior-year quarter, average analyst estimates predict Express Scripts Holding's revenues will grow 133.9% and EPS will grow 15.5%.
The average estimate for revenue is $26.57 billion. On the bottom line, the average EPS estimate is $0.82.
Last quarter, Express Scripts Holding reported revenue of $12.13 billion. GAAP reported sales were 9.4% higher than the prior-year quarter's $11.09 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.73. GAAP EPS of $0.55 for Q1 were 9.8% lower than the prior-year quarter's $0.61 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 6.9%, 20 basis points better than the prior-year quarter. Operating margin was 4.9%, 10 basis points worse than the prior-year quarter. Net margin was 2.2%, 70 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $92.70 billion. The average EPS estimate is $3.54.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 714 members out of 759 rating the stock outperform, and 45 members rating it underperform. Among 183 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 172 give Express Scripts Holding a green thumbs-up, and 11 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Express Scripts Holding is outperform, with an average price target of $61.75.
The health-care investing landscape is littered with also-rans and a few major winners. Is Express Scripts Holding prepared for the future? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will deliver amazing returns during the next few years. Get instant access to this free report.
- Add Express Scripts Holding to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is the co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool owns shares of Express Scripts. Motley Fool newsletter services recommend Express Scripts. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Why Express Scripts Holding Company Broke Out in December
Express Scripts started to shake off the negative headwinds facing its industry last month.
3 Top Value Stocks to Buy in 2018
Express Scripts Holding Company, Horizon Pharma plc, and Sanofi plc are three cheap stocks worth considering in 2018.
Express Scripts (ESRX) Q3 2017 Earnings Conference Call Transcript
ESRX earnings call for the period ending September 30, 2017.